• Syneron Bio Closes $150M Series B Funding Round
BioTrack Capital - Latest News and Investment Deals
  • All Technology
  • AI
  • Autonomy
  • B2B Growth
  • Big Data
  • BioTech
  • ClimateTech
  • Consumer Tech
  • Cybersecurity
  • DevOps
  • Digital Marketing
  • Ecommerce
  • EdTech
  • Enterprise
  • FinTech
  • GovTech
  • Hardware
  • HealthTech
  • HRTech
  • LegalTech
  • Nanotech
  • PropTech
  • Quantum
  • Robotics
  • SaaS
  • SpaceTech
AllNewsDealsSocialBlogsVideosPodcastsDigests

Technology Pulse

EMAIL DIGESTS

Daily

Every morning

Weekly

Tuesday recap

Top Publishers

Top Creators

  • Ryan Allis

    Ryan Allis

    207 followers

  • Elon Musk

    Elon Musk

    79 followers

  • Sam Altman

    Sam Altman

    68 followers

  • Mark Cuban

    Mark Cuban

    56 followers

  • Jack Dorsey

    Jack Dorsey

    39 followers

See More →

Top Companies

  • SaasRise

    SaasRise

    209 followers

  • Anthropic

    Anthropic

    40 followers

  • OpenAI

    OpenAI

    22 followers

  • Hugging Face

    Hugging Face

    15 followers

  • xAI

    xAI

    12 followers

See More →

Top Investors

  • Andreessen Horowitz

    Andreessen Horowitz

    16 followers

  • Y Combinator

    Y Combinator

    15 followers

  • Sequoia Capital

    Sequoia Capital

    12 followers

  • General Catalyst

    General Catalyst

    8 followers

  • A16Z Crypto

    A16Z Crypto

    5 followers

See More →
NewsDealsSocialBlogsVideosPodcasts
HomeBioTrack Capital
BioTrack Capital logo

BioTrack Capital

0 followers

About BioTrack Capital

BioTrack Capital is an investment firm focused on the biotech and life sciences sectors, building and managing a curated portfolio of companies. The firm presents its operations through an online platform highlighting its portfolio, team, news, and viewpoints, with indications of a China-based presence. The branding emphasizes a partnership approach, with messaging like "Better Choice" and "Better Partner" to reflect its investor relationships. While the site showcases its portfolio and team sections, it positions itself as a capital partner in biotech ventures.

Recent News

No recent news for this company.

Recent Deals

Syneron Bio Closes $150M Series B Funding Round

April 3, 2026

Key Team Members

Kai Liu

Managing Director

Jennifer Zhang

Vice President, Investment

Feng Tao

Founding Partner

Kevin Chen

Founding Partner

Jiacong Guo

Executive Director

Key Facts

HQ Location

Shanghai, China

Employees

1 - 10

Status

Investor

Investor Type

Venture Investor

Website

https://biotrackcapital.com